Whitworth elected to Genzyme’s board – Boston Globe
By Dr. Matthew Watson
 The Money Times | Whitworth elected to Genzyme's board Boston Globe Genzyme Corp., the large Cambridge biotechnology company, said that that Ralph Whitworth, principal and co-founder of Relational Investors LLC, ... Genzyme moves to strengthen defenses against IcahnReuters Genzyme adds Whitworth to block IcahnPharma Times Ralph Whitworth Elected to Genzyme's Board of DirectorsMarketWatch (press release) Boston Herald -Boston Business Journal -Xconomy all 61 news articles » |
Uncategorized
Comments Off on Whitworth elected to Genzyme’s board – Boston Globe |
April 16th, 2010
This author published 5472 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research